John L Mclean, MD | |
1607 South Locust Ave, Lawrenceburg, TN 38464 | |
(615) 620-2320 | |
Not Available |
Full Name | John L Mclean |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Location | 1607 South Locust Ave, Lawrenceburg, Tennessee |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649343310 | NPI | - | NPPES |
01069632 | Other | TN | AMERIGROUP TENNCARE ONLY |
3384834 | Medicaid | TN | |
4059473 | Other | TN | BLUE CROSS/BLUE SHIELD OF TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | MD37375 (Tennessee) | Primary |
Entity Name | Medstream Anesthesia Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649616160 PECOS PAC ID: 7416198049 Enrollment ID: O20140314001426 |
News Archive
A first-in-human study with a new class of antisense oligonucleotide therapeutics showed the ability to target the RNA-silencing drug to the liver, resulting in improved potency and safety at therapeutic doses. The design and results of this trial, conducted in healthy human volunteers are reported in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
A novel mechanism has been identified that might explain why a rare mutation is associated with familial Alzheimer's disease in a new study by investigators at the University of Chicago.
Adults with cerebral palsy have a higher risk of developing depression and anxiety than their peers without the condition, a new study in the journal JAMA Neurology reports.
In the last few years, "personalized medicine" using genetic or other molecular biology-based diagnostic tests to customize treatment for a particular patient has emerged as a powerful new tool for health care.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
John L Mclean, MD Po Box 440013, Nashville, TN 37244-0013 Ph: (615) 620-2320 | John L Mclean, MD 1607 South Locust Ave, Lawrenceburg, TN 38464 Ph: (615) 620-2320 |
News Archive
A first-in-human study with a new class of antisense oligonucleotide therapeutics showed the ability to target the RNA-silencing drug to the liver, resulting in improved potency and safety at therapeutic doses. The design and results of this trial, conducted in healthy human volunteers are reported in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
A novel mechanism has been identified that might explain why a rare mutation is associated with familial Alzheimer's disease in a new study by investigators at the University of Chicago.
Adults with cerebral palsy have a higher risk of developing depression and anxiety than their peers without the condition, a new study in the journal JAMA Neurology reports.
In the last few years, "personalized medicine" using genetic or other molecular biology-based diagnostic tests to customize treatment for a particular patient has emerged as a powerful new tool for health care.
› Verified 7 days ago